Figure 2
Figure 2. Cumulative incidence of t-MDS/AML in patients treated on COG therapeutic trial INT-0091.

Cumulative incidence of t-MDS/AML in patients treated on COG therapeutic trial INT-0091.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal